About Veralight
Veralight is a company based in Albuquerque (United States) founded in 2004. It operates as a B2B. Veralight has raised $25.23 million across 4 funding rounds from investors including Dow, Psilos Group and Garywoitzik. Veralight operates in a competitive market with competitors including Viome Life Sciences, Proteomics International, Tethys BioScience, Mellitus and SmartZyme, among others.
- Headquarter Albuquerque, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.23 M (USD)
in 4 rounds
-
Latest Funding Round
$200 K (USD), Series C
Dec 19, 2012
-
Investors
Dow
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Veralight
Veralight has successfully raised a total of $25.23M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $200 thousand completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Veralight
Veralight has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Dow, Psilos Group and Garywoitzik.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage investments focused on US tech and life sciences.
|
Locked | Locked | Locked | |
|
Early-stage investments in US tech and life sciences are targeted.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Veralight
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Veralight
Investment portfolio details for Veralight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Veralight
Detailed financials for Veralight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Veralight Comparisons
Peer comparison for Veralight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Veralight
Veralight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Proteomics International, Tethys BioScience, Mellitus and SmartZyme, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| Locked | Locked | Locked |
Develops biological markers for medical diagnostic applications.
|
|
| Locked | Locked | Locked |
In vitro diagnostic test for Gestational Diabetes Mellitus (GDM)
|
|
| Locked | Locked | Locked |
Proprietary protein engineering technology is developed for diabetes products.
|
Detailed competitors of Veralight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Veralight
Complete news archive for Veralight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veralight
Veralight was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Veralight is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Veralight is a funded company, having raised a total of $25.23M across 4 funding rounds to date.
Veralight, based in Albuquerque, focuses on providing healthcare solutions, medical diagnostics, biomarker screening, and diabetes detection. Offers biomarker screening solutions for early diabetes detection. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Veralight's top competitors include Viome Life Sciences, Proteomics International and Mellitus.
Veralight has 5 investors. Key investors include Dow, Psilos Group, Garywoitzik, Wasatch Advisors, and Signal Peak.